Literature DB >> 16701534

Regulation of neurotoxin complex expression in Clostridium botulinum strains 62A, Hall A-hyper, and NCTC 2916.

Marite Bradshaw1, Sean S Dineen, Nicole D Maks, Eric A Johnson.   

Abstract

The kinetics of botulinum toxin gene expression have been investigated in Clostridium botulinum type A strains 62A, Hall A-hyper, and type A(B) strain NCTC 2916 during the growth cycle. The analyses were performed in TPGY and type A Toxin Production Media (TPM). The mRNA transcript levels encoding the proteins of the neurotoxin complex were determined using Northern analyses. Neurotoxin concentrations in culture supernatants and lysed cell pellets were assayed using ELISA, Western blots, and mouse bioassay. Proteolytic activation of botulinum neurotoxin during the growth cycle was evaluated by Western blots. For all three strains, mRNA transcripts for the toxin complex genes were initially detected in early log phase, reached peak levels in early stationary phase, and rapidly decreased in mid-to-late stationary phase and during lysis. Toxin expression varied depending on the strain and growth medium. Toxin production was highest in strain Hall A-hyper, followed by NCTC 2916 and 62A. For C. botulinum strain Hall A-hyper, cell lysis and toxin release into the supernatant occurred rapidly for cells grown in TPM, while cells grown in TPGY remained in stationary phase with minimal lysis and toxin release through 96 h of growth. In contrast, strains 62A and NCTC 2916 lysed more extensively than Hall A-hyper in TPGY. TPM supported higher toxin production and activation than TPGY in strains 62A and Hall A-hyper. These data support that the genes of the botulinum neurotoxin complex are temporally expressed during late-log and early stationary phase and that toxin complex formation depends on the strain and growth medium. Botulinum toxin synthesis and activation appears to be a complex process that is highly regulated by nutritional and environmental conditions. Further research is needed to elucidate the sensing mechanisms and genetic regulatory factors controlling these processes.

Entities:  

Year:  2004        PMID: 16701534     DOI: 10.1016/j.anaerobe.2004.07.001

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  28 in total

1.  Regulation of neurotoxin production and sporulation by a Putative agrBD signaling system in proteolytic Clostridium botulinum.

Authors:  Clare M Cooksley; Ian J Davis; Klaus Winzer; Weng C Chan; Michael W Peck; Nigel P Minton
Journal:  Appl Environ Microbiol       Date:  2010-05-07       Impact factor: 4.792

2.  Analysis of genomic differences among Clostridium botulinum type A1 strains.

Authors:  Ping-Ke Fang; Brian H Raphael; Susan E Maslanka; Shuowei Cai; Bal Ram Singh
Journal:  BMC Genomics       Date:  2010-12-23       Impact factor: 3.969

3.  Plasmid encoded neurotoxin genes in Clostridium botulinum serotype A subtypes.

Authors:  Kristin M Marshall; Marite Bradshaw; Sabine Pellett; Eric A Johnson
Journal:  Biochem Biophys Res Commun       Date:  2007-07-20       Impact factor: 3.575

4.  Immunoprecipitation of native botulinum neurotoxin complexes from Clostridium botulinum subtype A strains.

Authors:  Guangyun Lin; William H Tepp; Marite Bradshaw; Chase M Fredrick; Eric A Johnson
Journal:  Appl Environ Microbiol       Date:  2014-10-31       Impact factor: 4.792

5.  Positive regulation of botulinum neurotoxin gene expression by CodY in Clostridium botulinum ATCC 3502.

Authors:  Zhen Zhang; Elias Dahlsten; Hannu Korkeala; Miia Lindström
Journal:  Appl Environ Microbiol       Date:  2014-10-03       Impact factor: 4.792

6.  Holotoxin Activity of Botulinum Neurotoxin Subtype A4 Originating from a Nontoxigenic Clostridium botulinum Expression System.

Authors:  Marite Bradshaw; William H Tepp; Regina C M Whitemarsh; Sabine Pellett; Eric A Johnson
Journal:  Appl Environ Microbiol       Date:  2014-09-19       Impact factor: 4.792

7.  Purification and Characterization of Recombinant Botulinum Neurotoxin Serotype FA, Also Known as Serotype H.

Authors:  Gavin Hackett; Kevin Moore; David Burgin; Fraser Hornby; Bryony Gray; Mark Elliott; Imran Mir; Matthew Beard
Journal:  Toxins (Basel)       Date:  2018-05-11       Impact factor: 4.546

8.  Conjugative botulinum neurotoxin-encoding plasmids in Clostridium botulinum.

Authors:  Kristin M Marshall; Marite Bradshaw; Eric A Johnson
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

9.  Construction of a nontoxigenic Clostridium botulinum strain for food challenge studies.

Authors:  Marite Bradshaw; Kristin M Marshall; John T Heap; William H Tepp; Nigel P Minton; Eric A Johnson
Journal:  Appl Environ Microbiol       Date:  2009-11-20       Impact factor: 4.792

10.  Comparison of assembled Clostridium botulinum A1 genomes revealed their evolutionary relationship.

Authors:  Virginia Ng; Wei-Jen Lin
Journal:  Genomics       Date:  2013-12-22       Impact factor: 5.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.